0 results available. Select is focused ,type to refine list, press Down to open the menu,
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and comme...
The following section summarizes insights on INmune Bio Inc's Dividend Adjustment Factor:
We've identified the following companies as similar to INmune Bio Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Dividend Adjustment Factor in the dividends category include:
This item allows you to adjust the stock price return over a period of time to include income from dividends paid by the company.
The chart above depicts the distribution of dividend adjustment factor for companies operating in the Healthcare sector in the Developed economic region. Over 3,150 companies were considered in this analysis, and 3,144 had meaningful values. The average dividend adjustment factor of companies in the sector is 1.00 with a standard deviation of 0.00.
INmune Bio Inc's Dividend Adjustment Factor of 1.00 ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,158 |
| Included Constituents | 3,144 |
| Min | 1.00 |
| Max | 1.00 |
| Median | 1.00 |
| Mean | 1.00 |
| Standard Deviation | 0.00 |
You can find companies with similar dividend adjustment factor using this stock screener.